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Abstract
Background: A case report is a narrative that describes, for medical, scientific, or educational purposes, a medical
problem experienced by one or more patients. Case reports written without guidance from reporting standards are
insufficiently rigorous to guide clinical practice or to inform clinical study design.
Primary Objective. Develop, disseminate, and implement systematic reporting guidelines for case reports.
Methods: We used a three-phase consensus process consisting of (1) pre-meeting literature review and interviews
to generate items for the reporting guidelines, (2) a face-to-face consensus meeting to draft the reporting
guidelines, and (3) post-meeting feedback, review, and pilot testing, followed by finalization of the case report
guidelines.
Results: This consensus process involved 27 participants and resulted in a 13-item checklist—a reporting guideline
for case reports. The primary items of the checklist are title, key words, abstract, introduction, patient information,
clinical findings, timeline, diagnostic assessment, therapeutic interventions, follow-up and outcomes, discussion,
patient perspective, and informed consent.
Conclusions: We believe the implementation of the CARE (CAse REport) guidelines by medical journals will
improve the completeness and transparency of published case reports and that the systematic aggregation of
information from case reports will inform clinical study design, provide early signals of effectiveness and harms, and
improve healthcare delivery.
Keywords: Case report, Case study, EQUATOR Network, Patient reports, Meaningful use, Health research reporting
guidelines
Introduction
A case report is a detailed narrative that describes, for
medical, scientific, or educational purposes, a medical
problem experienced by one or several patients
Case reports present clinical observations customarily
collected in healthcare delivery settings. They have
proved helpful in the identification of adverse and bene-
ficial effects, the recognition of new diseases, unusual
forms of common diseases, and the presentation of rare
diseases [1]. For example, our understanding of the rela-
tionship between thalidomide and congenital abnormal-
ities [2] and the use of propranolol for the treatment of
infantile hemangiomas began with case reports [3]. Case
reports may generate hypotheses for future clinical stud-
ies, prove useful in the evaluation of global convergences
of systems-oriented approaches, and guide the
individualization and personalization of treatments in
clinical practice [4,5]. Furthermore, case reports offer a
structure for case-based learning in healthcare education
and may facilitate the comparison of healthcare educa-
tion and delivery across cultures.
Case reports are common and account for a growing
number of articles in medical journals [6]; however their
quality is uneven [7,8]. For example, one study evaluated
1316 case reports from four peer-reviewed emergency-
medicine journals and found that more than half failed
to provide information related to the primary treatment
that would have increased transparency and replication
[9]. Written without the benefit of reporting guidelines,
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case reports often are insufficiently rigorous to be aggre-
gated for data analysis, inform research design, or guide
clinical practice [7,9].
Reporting guidelines exist for a variety of study designs
including randomized controlled trials (Consolidated
Standards of Reporting Trials, or CONSORT) [10], ob-
servational studies (Strengthening the Reporting of
Observational studies in Epidemiology, or STROBE) [11],
and systematic reviews and meta-analyses (Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses, or PRISMA) [12]. Empirical evidence suggests
that a journal’s adoption of the CONSORT statement
as a guide to authors is associated with an increase in
the completeness of published randomized trials [13].
Guidelines have been developed for adverse-event case
reports [14]; however, general reporting guidelines for
case reports do not exist. Our primary objective was to




We followed the Guidance for Developers of Health
Research Reporting Guidelines [15] and developed a
three phase consensus process [16]. This consisted of (1)
a pre-meeting literature review followed by interviews to
generate items for a case report checklist, (2) a face-to-
face consensus meeting for drafting a reporting guideline,
and (3) post-meeting feedback and pilot testing followed
by finalization of the case report guidelines.
Participants
We contacted 28 individuals who fulfilled at least one of
four criteria [17-19]: (1) publication of articles related to
case reports; (2) publication of a manual, handbook, or
method guidelines related to case reports; (3) publication
of a systematic review of methods or reporting related to
case reports; and (4) publication of other reporting
guidelines for clinical research.
Consensus process
Phase 1: Four of the authors, the steering committee
(JG, GK, DM, and DR), searched the literature for publi-
cations on the role of case reports, recommendations for
their publication, and surveys on reporting quality. A let-
ter was sent to 28 potential participants explaining the
purpose of the meeting, details of the consensus tech-
nique, and requesting their participation in generating
specific recommendations for case reporting. Twenty-
seven people agreed to participate and were scheduled
for a telephone interview and sent a selection of key arti-
cles on case reports. During the telephone interview,
participants were asked (1) what information was re-
quired to be included in case-reporting guidelines, (2)
the rationale for their suggestions, and (3) for references
that supported their reasoning.
Three of the authors (JG, GK, and DR) grouped the rec-
ommendations from the literature search and interviews
by theme together with their rationale, references, and op-
erational definitions. No quantitative scoring was done.
Phase 2: The face-to-face consensus meeting at the
University of Michigan in Ann Arbor (October 2012) in-
cluded 18 participants from Phase 1, one research assist-
ant and two student observers. The meeting began with
a review of the blinded recommendations elicited during
the Phase 1 interviews, in whole group and small group
sessions. On the second day, open discussion of each po-
tential item continued, during which clarifications, opin-
ions, justifications, operational definitions, and new
ideas were expressed. By the end of the second day, the
group had agreed upon a set of preliminary reporting
recommendations.
Phase 3: The draft checklist was refined by the steering
committee and sent for two rounds of review to the
complete group (Phase 1 and 2 participants). The final-
ized reporting guidelines incorporated the feedback from
the entire CARE group.
Results
The CAse REport (CARE) guidelines checklist is structured
to correspond with key components of a case report and
capture useful clinical information (including ‘meaningful
use’ information mandated by some insurance plans).
The checklist begins with a statement that describes
the narrative of a case report. The meeting CARE group
felt that a case report should tell a story using prose that
has a consistent style across all sections, including the
rationale for any conclusions and take-away messages.
We recommend a timeline (item 7) in the form of a
table or figure that gives the specific dates and times of
important components of the case. This might include
family and past medical history, genetic information,
current symptoms, diagnostic test results, interventions,
and events that occurred during follow-up. The timeline
should show how the key events of the case unfolded.
We created separate checklist items for diagnostic
assessments (item 8) and therapeutic interventions (item 9)
with the recognition that both items will often be relevant
in a case report.
The group discussed at length whether to include the
patient’s perspective on his or her experience. In the
end, we advocated for patient-reported outcomes and
experiences whenever possible (item 12). There was also
discussion about the need for guidelines for patient-
reported outcomes of their care. In a similar vein, a
recent extension of the CONSORT statement was
published for patient-reported outcomes in randomized
trials; CONSORT-PRO [20].
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Finally, we included an item on informed consent (item
13). We believe that authors have an ethical duty to obtain
informed consent from the patient to publish patient in-
formation in a case report. Consent becomes informed
when the patient or a relative reads the case report and
approves its contents. If the patient cannot give consent
and attempts to find a relative to give proxy consent have
failed, the authors should seek permission to publish from
an institutional committee. There may be other circum-
stances where an ethics committee or Institutional Review
Board (IRB) approval may be necessary. The CARE guide-
lines are shown in the following Table 1.
Table 1 The CARE guidelines checklist
The Narrative: A case report tells a story in a narrative format that includes the presenting concerns, clinical findings, diagnoses, interventions,
outcomes (including adverse events), and follow-up. The narrative should include a discussion of the rationale for any conclusions and any take-away
messages.
Item name Item no. Brief description
Title 1 The words “case report” (or “case study”) should appear in the title along with phenomenon
of greatest interest (eg, symptom, diagnosis, test, intervention)
Keywords 2 The key elements of this case in 2-5 words
Abstract 3 a) Introduction—What does this case add?
b) Case Presentation:
- The main symptoms of the patient
- The main clinical findings
- The main diagnoses and interventions
- The main outcomes
c) Conclusion—What were the main “take-away” lessons from this case?
Introduction 4 Brief background summary of this case referencing the relevant medical literature
Patient Information 5 a) Demographic information (eg, age, gender, ethnicity, occupation)
b) Main symptoms of the patient (his or her chief complaints)
c) Medical, family, and psychosocial history—including diet, lifestyle, and genetic information
whenever possible, and details about relevant comorbidities including past interventions and
their outcomes
Clinical Findings 6 Describe the relevant physical examination (PE) findings
Timeline 7 Depict important dates and times in this case (table or figure)
Diagnostic Assessment 8 a) Diagnostic methods (eg, PE, laboratory testing, imaging, questionnaires)
b) Diagnostic challenges (eg, financial, language/cultural)
c) Diagnostic reasoning including other diagnoses considered
d) Prognostic characteristics (eg, staging) where applicable
Therapeutic Intervention 9 a) Types of intervention (eg, pharmacologic, surgical, preventive, self-care)
- Administration of intervention (eg, dosage, strength, duration)
- Changes in intervention (with rationale)
Follow-up and Outcomes 10 a) Summarize the clinical course of all follow-up visits including
- Clinician and patient-assessed outcomes
- Important follow-up test results (positive or negative)
- Intervention adherence and tolerability (and how this was assessed)
- Adverse and unanticipated events
Discussion 11 a) The strengths and limitations of the management of this case
b) The relevant medical literature
c) The rationale for conclusions (including assessments of cause and effect)
d) The main “take-away” lessons of this case report
Patient Perspective 12 The patient should share his or her perspective or experience whenever possible
Informed Consent 13 Did the patient give informed consent? Please provide if requested
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Discussion
This 13-item checklist provides a framework to satisfy
the need for completeness and transparency for pub-
lished case reports. We attempted to strike a balance
between adequate detail and the concise writing that is
one of the appealing characteristics of a case report. Our
consensus process resulted in a set of essential items for
authors to consider when submitting a case report for
publication.
While case reports have long been an important
source of new ideas and information in medicine [21], it
appears that case reports are likely to begin to play a
role in the discovery of what works and for whom.
BioMed Central launched the Journal of Medical Case
Reports in 2007 [22] and a Cases Database in 2012 with
more than 11,000 published case reports from 50 med-
ical journals. In 6 months, it has grown to more than
26,000 case reports from 212 medical journals [23]. The
CARE guidelines checklist is part of a growing effort to
improve the reporting of case reports.
There is substantial empirical evidence that reporting
guidelines improve the completeness of published scien-
tific reports eg, see references [13,24,25]. A recent
Cochrane review examining the influence of journal
endorsement of the CONSORT statement on reporting
included 53 publications assessing 16,604 randomized
controlled trials and found that CONSORT-endorsing
journals consistently have better overall reporting [13].
However, the potential impact of the CONSORT state-
ment and related reporting guidelines has not been fully
realized. A study examining the instructions to peer
reviewers of 116 health research journals found that only
41 (35%) provided online instructions to peer reviewers.
Of those, only 19 (46%) mentioned or referred to
reporting guidelines as a useful resource [26]. In re-
sponse, the authors provide several recommendations
for editors to improve the peer review of submitted
manuscripts, suggesting that journals have a responsibil-
ity to support peer reviewers [26].
The developers of reporting guidelines have a respon-
sibility to plan a dissemination and implementation
strategy that supports guidelines utilization [15]. Our
efforts have several components:
1. The CARE guidelines will be presented at
international conferences and workshops including
the Peer Review and Biomedical Publication
Congress in Chicago on September 10, 2013.
2. This article will be published simultaneously in
multiple medical journals and outreach to the 212
journals depositing case reports into the BioMed
Central Case Report Database.
3. We will develop a more detailed explanation and
elaboration article to outline the rationale for each
item and include empirical evidence and examples of
good reporting from published case reports.
4. The CARE guidelines are being pilot tested, and
preliminary results support the guidelines as currently
written (personal communication with Helmut Kiene,
Erika Oberg, Bill Manahan). Guidelines extensions for
specialties are being developed.
5. The CARE guidelines and related documents will be
available on a dedicated website (www.CARE-
statement.org), the EQUATOR Network website
(www.equator-network.org), and translated into
multiple languages.
6. Authors, journal editors, peer reviewers and the
wider medical community are encouraged to use the
CARE checklist and provide feedback that can be
incorporated into regular updates of the CARE
guidelines.
7. We will conduct and support research into the
impact of the CARE guidelines on the reporting of
case reports.
Limitations
The CARE guidelines and their development have sev-
eral possible limitations. First, these guidelines were de-
veloped through a consensus method and thus represent
the opinions of the participants. However, consensus
was easily reached during our meeting, we referred to
the empirical evidence where available, and we received
feedback from a wide selection of individuals, beyond
those involved in our consensus meeting. Second, we
recognize that causality determinations are a challenge
for case reports even when following reporting guide-
lines [27,28]. The CARE guidelines emphasize informa-
tion quality independent of causality assessments.
Different specialties, practitioners, and patients are likely
to require extensions of the CARE guidelines with spe-
cialty specific information. We welcome discussions with
groups interested in using the CARE guidelines as the
basis for their specific reporting needs.
Though not mentioned in our guidelines, medical
journals often require authors to address three issues:
(a) potential competing interests, (b) de-identification of
patient-related data, and (c) ethics committee or Institu-
tional Review Board (IRB) approval if obtained or
necessary.
Conclusions
Anticipating a long future for case reports, we have pro-
vided guidance in the form of reporting standards for use
by healthcare stakeholders around the world. The growth
of case reports in an era in which clinical trials and sys-
tematic reviews dominate the tables of content of medical
journals indicates that case reports have value, particularly
with the increasing importance of individualized care.
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Unlike randomized controlled trials, case reports are indi-
vidual reports related to the care of individual patients
where the sample size is one. When systematically col-
lected and combined into larger datasets, they can be ana-
lyzed, enhancing the early discovery of effectiveness and
harms.
We anticipate that the analysis of systematically ag-
gregated information from patient encounters (now
mandated by some insurance plans) will provide scal-
able, data-driven insights into what works for which
patients in real time, facilitating comparisons across
medical systems and cultures. Practitioners will soon be
able to provide—and in some cases they are required to
provide—patients with information from their encounters.
This will transform how we think about “evidence” and
revolutionize its creation, diffusion, and use—opening
new opportunity landscapes. When it becomes clear how
new data contributes to evidence, the stewardship needed
to produce high-quality data will be more rewarding and
our attitude toward “observation” will shift. The CARE
guidelines provide a framework to satisfy the need for pre-
cision, completeness, and transparency.
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